Can-Fire Biopharma Ltd., of Petach Tikva, Israel, was granted Japanese Patent No. 5467872, “Process for the Synthesis of IB-MECA.” The patent covers a method for the chemical synthesis of the A3 adenosine receptor agonist, IB-MECA, the active pharmaceuticals ingredient.